Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
2seventy bio, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Leschly Nick (President and CEO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 9,312 shares
@ $5.4865, valued at
$51.1k
|
|
| 08/24/2023 |
4
| Gregory Philip D (Chief Scientific Officer) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 6,159 shares
@ $5.4865, valued at
$33.8k
|
|
| 08/24/2023 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 7,031 shares
@ $5.4865, valued at
$38.6k
|
|
| 08/16/2023 |
4
| Kynam Global Healthcare Master Fund, LP (10% Owner) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Bought 179,000 shares
@ $5.94, valued at
$1.1M
Bought 50,000 shares
@ $5.8, valued at
$290k
Bought 100,000 shares
@ $5.85, valued at
$585k
Bought 100,000 shares
@ $5.96, valued at
$596k
Bought 86,414 shares
@ $5.96, valued at
$515k
Bought 86,414 shares
@ $5.96, valued at
$515k
|
|
| 08/16/2023 |
3
| Kynam Global Healthcare Master Fund, LP (10% Owner) has filed a Form 3 on 2seventy bio, Inc. |
| 08/14/2023 |
4
| Kynam Capital Management, LP (10% Owner) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Bought 179,000 shares
@ $5.94, valued at
$1.1M
Bought 50,000 shares
@ $5.8, valued at
$290k
Bought 100,000 shares
@ $5.85, valued at
$585k
Bought 100,000 shares
@ $5.96, valued at
$596k
Bought 86,414 shares
@ $5.96, valued at
$515k
Bought 86,414 shares
@ $5.96, valued at
$515k
|
|
| 08/14/2023 |
3
| Kynam Capital Management, LP (10% Owner) has filed a Form 3 on 2seventy bio, Inc. |
| 08/07/2023 |
4
| Leschly Nick (President and CEO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 9,060 shares
@ $6.1257, valued at
$55.5k
|
|
| 08/07/2023 |
4
| Gregory Philip D (Chief Scientific Officer) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 3,966 shares
@ $6.1257, valued at
$24.3k
|
|
| 08/07/2023 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 6,906 shares
@ $6.1257, valued at
$42.3k
|
|
| 06/15/2023 |
4
| Ibrahim Ramy (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 06/15/2023 |
4
| Torres Denice (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 06/15/2023 |
4
| Maus Marcela V. (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 06/15/2023 |
4
| Glickman Sarah JS (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 06/15/2023 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 06/15/2023 |
4
| Wei Lin (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 4,200 shares
@ $0
Granted 8,450 options to buy
@ $11.81, valued at
$99.8k
|
|
| 03/09/2023 |
4
| Wei Lin (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 16,600 shares
@ $0
Granted 33,400 options to buy
@ $10.91, valued at
$364.4k
|
|
| 03/09/2023 |
3
| Wei Lin (Director) has filed a Form 3 on 2seventy bio, Inc. |
| 02/09/2023 |
4
| Heffron Nicola (COO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 60 shares
@ $14.7, valued at
$882 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Heffron Nicola (COO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 584 shares
@ $10.3347, valued at
$6k
|
|
| 01/11/2023 |
4
| Gregory Philip D (Chief Scientific Officer) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 3,794 shares
@ $10.3347, valued at
$39.2k
|
|
| 01/11/2023 |
4
| Baird William D III (CFO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 3,222 shares
@ $10.3347, valued at
$33.3k
|
|
| 01/11/2023 |
4
| Leschly Nick (President and CEO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 2,979 shares
@ $10.3347, valued at
$30.8k
|
|
| 12/06/2022 |
4
| Heffron Nicola (COO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 272 shares
@ $15.4328, valued at
$4.2k
|
|
| 11/23/2022 |
4
| Heffron Nicola (COO) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Sold 7,697 shares
@ $13.97, valued at
$107.5k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|